Twist Bioscience Corp vs Vertiv Holdings Co — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Vertiv Holdings Co trades at $305.2 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 20.6× Twist Bioscience Corp's market cap, and Vertiv Holdings Co pays a 0.09% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | VRT | |
|---|---|---|
Market Cap | $5.45B | $112.03B |
Sector | Health | Technology |
52-Week High | $102.88 | $376.23 |
52-Week Low | $24.16 | $121.82 |
Enterprise Value | $5.37B | $112.80B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →